Researchers assessed the therapeutic equivalence of proposed biosimilar CT-P41 and reference denosumab for the treatment of postmenopausal osteoporosis.

Nonadherence to pharmacological treatment in osteoporosis is a well-recognized problem. As in other chronic diseases, adherence to osteoporosis treatment is poor, resulting in enormous burden on ...

Osteoporosis is one of the common bone diseases resulted due to loss in bone mass. This disease starts developing when the body consumes more bone tissue than it produces; thus, this reduces the bone ...

My mother has osteoporosis, so I have a genetic risk ... I wasn’t keen on taking alendronate tablets, the standard treatment to slow down bone loss. My mother takes them and they are effective ...

Millions of postmenopausal women find themselves facing a diagnosis of osteoporosis, but what does that mean for their daily ...

It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. Osteoporosis is a condition that causes bones to ...

A common medication that is taken by more than 3 million Brits every single day could be increasing the risk of osteoporosis, ...

The Philippine Orthopaedic Association (POA) marked a milestone with its 75th Annual Congress held from Nov. 13 to 16, 2024 ...

Osteoporosis is a bone disease characterized ... you should ask your doctor if you need medication. Aim for 30 minutes of weight-bearing exercise at least 4 days a week, combined with muscle ...

Bone health experts are urging Filipinos, especially those aged 50 and above, and their families, to prioritize osteoporosis ...